pharma · Acute Myeloid Leukemia
Hutchison MediPharma
Hutchison Medipharma Limited
Hutchison Medipharma is a pharma organization headquartered in CN. Primary therapeutic focus areas include Acute Myeloid Leukemia. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to
Hong Kong, CN HQ
683 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Hong Kong, CN
- Employees
- 683
- Programs
- 1
- Drugs
- 1
- Patents
- 0
HMPL-306
Phase 1 · small molecule · Acute Myeloid Leukemia
HMPL-306 for Acute Myeloid Leukemia is a Phase 1 program (small_molecule) at Hutchison Medipharma Limited with 1 ClinicalTrials.gov record(s).
Internal code 2018-306-00CH1
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Hutchison Medipharma Limited
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Acute Myeloid Leukemia
- Status
- active
- Trials
- 1